Dean Spurden
Director Health Economics and Outcomes Research (Neuroscience) @Ipsen
Signup · Get unlimited contacts
WORK HISTORY
Director Health Economics and Outcomes Research (Neuroscience) @Ipsen
Slough, GB
Responsible for the overall quality, scientific and technical excellence of Health Economic and Outcomes Research deliverables for both early and In-Line Neuroscience assets. • Co-led the development an Integrated Evidence Generation Plan to maximise commercialisation of an In-Line Asset. • Assisted in developing HEOR capabilities, review process and governance which has led to a more robust study review process and defined HEOR activities. • Assisted country colleagues with local authority renegotiations and reimbursement strategy / submissions in line with global strategy leading to Country reimbursement. • Updated the Global Value Dossier and Payer Value Proposition of Dysport which aided in country reimbursement, funding and formulary listing negotiations. • Developed the Global Submission package for a new indication of an In-Line asset which gave countries the evidence required for country market access. • Developed both early stage and Full Cost utility analysis models for key assets.
EDUCATION
University of Oxford
Masters in Evidence Based Healthcare, Evidence Based Healthcare
University of Sunderland
PhD, Neurosciences
University of Sunderland
BSc Hons, Applied Physiology
The Open University
Certificate in Fundamentals of Senior Management, Business
ABOUT DEAN SPURDEN
I am a customer focussed and delivery orientated team player with 25 years of experience in the pharmaceutical industry. My current role is the Global Director for Neuroscience HEOR for IPSEN, UK. I am responsible for the overall quality of scientific and technical excellence of Health Economic and Outcomes Research deliverables for both early and In-Line Neuroscience assets. In Pfizer I worked in the Clinical Research (phases II-IV), Evidence Based Medicine and Outcomes Research arenas. I have contributed to both pre- and post-marketing medical research functions across a range of therapeutic areas including Neuroscience, advanced/metastatic Breast Cancer, Inflammation and Rare Diseases. In my most recent positions, I have delivered credible real-world evidence of clinical outcomes, economic and quality of life impacts. I have supported regulatory submissions and optimised product commercialisation. I worked closely with cross functional colleagues in Commercial, Medical, Regulatory, and Market Access at the global, regional, and country level in order to inform decision making, support formulary acceptance, and to obtain access for the appropriate use of medicines by patients. My experience is primarily in development and execution of systematic literature reviews, UK Health Technology Appraisals, conducting Non-Interventional Outcomes Research based studies and delivering compelling evidence for a product’s Value Proposition. I hold a BSc degree in Applied Physiology, an MSc in Evidence Based Healthcare and a PhD in Neurochemical Pathology.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.